Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Pharmos(PARS) -- Ignore unavailable to you. Want to Upgrade?

To: David Israel-Rosen who wrote (675)	5/3/1998 11:00:00 AM
From: InvestorLady	Read Replies (1) \| Respond to of 1491

<<When a optamologists can get $1,000 for operating why should he settle for a $75 office visit>> OK, first you say they are lazy and want to golf more than they do. Now you say they will perform more surgeries with less office visits. Which is it? And are they backlogued with surgeries currently, do they have the ability to perform more surgeries? It seems to me the benefits here are improved patient care with less side effects and that the product is being sold in a channel that has established relationships via a major player in the ophthalmology market. Just thinking out loud... Lady